NCT02426359
- Conditions
- Moderate to Severe Atopic Dermatitis
- Locations
-
- Denver, Colorado, United States
- Berlin, New Jersey, United States
- East Windsor, New Jersey, United States
- Buffalo, New York, United States
Clinical trial condition
Moderate to Severe Atopic Dermatitis
Explore clinical trials studying Moderate to Severe Atopic Dermatitis. Study availability and eligibility vary by location and protocol.
14 public trials
3 recruiting studies
Moderate to Severe Atopic Dermatitis trial results
NCT00148746
- Conditions
- Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dermatitis, Dermatitis, Atopic, +9 more
- Locations
-
- Department of Dermatology, TU Dresden Dresden, Germany
Active, Not Recruiting
A Phase 2b Study to Evaluate Rezpegaldesleukin (Rezpeg) in the Treatment of Adult Patients With Moderate-to-Severe Atopic Dermatitis
NCT06136741
- Conditions
- Moderate to Severe Atopic Dermatitis
- Locations
-
- Nektar Investigative Site Bryant, Arkansas, United States
- Nektar Investigative Site Fountain Valley, California, United States
- Nektar Investigative Site Los Angeles, California, United States
- Nektar Investigative Site Los Angeles, California, United States
Active, Not Recruiting
Efficacy and Safety Study of SHR-1819 Injection in Adult Patients With Severe Atopic Dermatitis
NCT06468956
- Conditions
- Moderate to Severe Atopic Dermatitis
- Locations
-
- Shanghai Fudan University HuaShan Hospital Shanghai, Shanghai Municipality, China